Objectives: To determine the prescription pattern of proton pump inhibitors (PPIs) at a tertiary hospital in Saudi Arabia. Methods: This study was a retrospective cohort design using medical records at the medical ward of King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. Data were collected from medical records of all patients admitted to the ward from October 2019 to March 2020. Results: A total of 1135 medical records were retrieved, of which 709 (62.5%) were prescribed PPIs. The frequency of PPIs prescribed was highest in March 2020 (21.7%) relative to the remaining months. Omeprazole was the most prescribed PPI (84.5%), compared to pantoprazole (15.5%). The PPIs were commonly administered through oral (56.7 %), compared to intravenous route (43.3%). The PPIs were prescribed to most patients (58.4%) on the first day of admission, and 6.5% were prescribed for indications other than those approved by the Food and Drug Administration. Conclusion: This study demonstrates that PPIs are frequently prescribed among most patients at the medical ward of KAUH, Kingdom of Saudi Arabia. We found that the PPIs were prescribed to many patients inappropriately (not based on clinical guidelines). These results suggest the need for educational interventions among physicians on rational prescription.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.